High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size

Ulger, Sukran; Demirci, Nilgun; Eroglu, Fatma; Cengiz, Huriye; Tunc, Mustafa; Tatci, Ebru; Yilmaz, Ulku; Cetin, Eren; Avci, Emine; CENGİZ, MUSTAFA

doi:10.1007/s00432-014-1591-9

High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size

Copy For Citation

Ulger S., Demirci N. Y. , Eroglu F. N. , Cengiz H. H. , Tunc M., Tatci E., ...More

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, no.3, pp.495-502, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 140 Issue: 3
Publication Date: 2014
Doi Number: 10.1007/s00432-014-1591-9
Journal Name: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.495-502
Hacettepe University Affiliated: Yes

Abstract

Objectives Despite radical radiotherapy and chemotherapy (CT), the prognosis of locally advanced nonsmall cell lung cancer (NSCLC) is poor. New prognostic indicators are being looked forward to improve the survival. [18F]-fluorodeoxyglucose (FDG) uptake on PET/CT has been observed as a prognostic marker mainly in early-stage disease. Our aim was to examine the prognostic value of FDG uptake in locally advanced NSCLC.